(Q40264789)

19 September 2017

Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells (English)

1 reference

19 September 2017

1 reference

Qi Cao

1

1 reference

19 September 2017

Xin Lu

series ordinal

2

1 reference

19 September 2017

You-Ji Feng

series ordinal

3

1 reference

19 September 2017

1 July 2006

1 reference

19 September 2017

1 reference

19 September 2017

16

1 reference

19 September 2017

671-677

1 reference

19 September 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cr.7310078

19 September 2017

0 references

cites work

Paradigms for primary prevention of ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

Deregulated GSK3beta activity in colorectal cancer: its association with tumor cell survival and proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

GSK-3: tricks of the trade for a multi-tasking kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

Glycogen synthase kinase 3: an emerging therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

Enhanced antitumour efficacy of gimatecan in combination with Bcl-2 antisense oligonucleotide in human melanoma xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

Wnt-signalling pathway in ovarian epithelial tumours: increased expression of beta-catenin and GSK3beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

Pharmacological inhibitors of glycogen synthase kinase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

A molecular mechanism for the effect of lithium on development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

Insulin-like growth factor-I inhibits dexamethasone-induced proteolysis in cultured L6 myotubes through PI3K/Akt/GSK-3beta and PI3K/Akt/mTOR-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

Regulation of glycogen synthase kinase 3beta and downstream Wnt signaling by axin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

CDK inhibitors: positive and negative regulators of G1-phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

The glamour and gloom of glycogen synthase kinase-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

Biological and chemical inhibitors of NF-kappaB sensitize SiHa cells to cisplatin-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310078

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CR.7310078

1 reference

Dimensions Publication ID

19 September 2017

1034472744

0 references

Fatcat ID

release_clusrx2ptfhyzjwhgzbcav5bke

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/clusrx2ptfhyzjwhgzbcav5bke

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference